Substituted Benzimidazole Derivatives As Melanocortin 4 Receptor Antagonists

  • Published: Apr 11, 2012
  • Earliest Priority: Oct 07 2010
  • Family: 1
  • Cited Works: 22
  • Cited by: 6
  • Cites: 3
  • Additional Info: Cited Works Published
Full-text?

The full document isn't yet available to us from the patent office.

Abstract

The present invention relates to substituted benzimidazole derivatives as melanocortin-4 receptor (MC-4R) modulators.


Claims

Information currently unavailable.

Download Citation


Sign in to the Lens

Feedback